Showing results (91-100 of 342) with videos related to
Sort By:
Pageof 35
BMC Pulmonary Medicine|December 13, 2021
Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapyMasato Karayama, Yusuke Inoue, Hideki Yasui, et al.Cancer Immunology, Immunotherapy : CII|April 27, 2011
Enhanced anti-tumor immunity by superantigen-pulsed dendritic cellsMasato Kato, Yutaro Nakamura, Takafumi Suda, et al.Respiratory Medicine Case Reports|March 4, 2022
Multiple organ infarction caused by aortic thrombus in a lung cancer patient with the <i>BRAF</i> mutationHirofumi Watanabe, Masato Karayama, Yusuke Inoue, et al.Scientific Reports|April 8, 2021
Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-rayMasato Karayama, Yoichiro Aoshima, Hideki Yasui, et al.Biological & Pharmaceutical Bulletin|June 3, 2021
Prediction of the Area under the Curve Using Limited-Point Blood Sampling in a Cocktail Study to Assess Multiple CYP ActivitiesMotoyasu Miura, Shimako Tanaka, Shinya Uchida, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2021
Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non-Small Cell Lung Cancer After Nivolumab TherapyMasato Karayama, Yusuke Inoue, Katsuhiro Yoshimura, et al.Respiratory Medicine Case Reports|March 21, 2022
Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case reportYasutaka Mochizuka, Tomoyuki Fujisawa, Yusuke Inoue, et al.Respiratory Medicine|March 30, 2010
Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosisKazuki Furuhashi, Takafumi Suda, Yutaro Nakamura, et al.Chemical & Pharmaceutical Bulletin|May 31, 2023
Palatability of Aripiprazole Gummies Prepared from Commercially Available Products: Pharmaceutical Formulation for Improving Patient AdherenceSayuri Kawamoto, Shimako Tanaka, Motoyasu Miura, et al.Lung Cancer (Amsterdam, Netherlands)|June 3, 2008
Phase II study of combination chemotherapy with S-1 and weekly cisplatin in patients with previously untreated advanced non-small cell lung cancerYuichi Ozawa, Naoki Inui, Tateaki Naitoh, et al.Pageof 35